The Company

Sunshine Biopharma Inc. is a Colorado corporation headquartered in the greater Montreal area (Canada). The Company is fully reporting in the U.S. ( and Canada ( Sunshine Biopharma’s shares of Common Stock are traded on the OTC market ( under the ticker symbol SBFM. Sunshine Biopharma is engaged in the following business operations:

Anticancer Drug Development
Since inception, Sunshine Biopharma has been involved in the development Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). These and other preclinical results have been published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012. Adva-27a is the only compound known that is capable of destroying Multidrug Resistant Cancer cells. The Company is planning to conduct Adva-27a Phase I Clinical Trials for Pancreatic Cancer indication at McGill University's Jewish General Hospital in Montreal (Canada). Sunshine Biopharma is direct owner of all worldwide patents covering Adva-27a, including all issued and pending patents under PCT/FR2007/000697 and PCT/CA2014/000029. Learn more…

Essential Supplements
In 2018, Sunshine Biopharma completed the development of Essential 9™, the first in a line of essential micronutrients products that the Company is planning to launch. On December 14, 2018, Health Canada issued NPN 80089663 through which it authorized Sunshine Biopharma to manufacture and sell the Essential 9™ product. Essential 9™ dietary supplement tablets contain a balanced formula of the 9 essential amino acids that the human body cannot make. Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes. Sunshine Biopharma’s Essential 9™ provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9™ is available in the US on and in Canada on Click here to learn more or to order through Amazon.

Generic Pharmaceuticals
Sunshine Biopharma has licensing agreements for the following four (4) generic prescription drugs:

  • Anastrozole for treatment of Breast Cancer
  • Letrozole for treatment of Breast Cancer
  • Bicalutamide for treatment of Prostate Cancer
  • Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)
These drugs will be available in Canadian pharmacies soon.

Press Releases

November 6, 2019
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin D™ Supplement

October 17, 2019
Sunshine Biopharma Initiates Adva-27a Xenograft Studies In Mice Carrying Different Types Of Human Cancer

September 3, 2019
Sunshine Biopharma Receives Vegan Certification for Essential 9™ Amino Acids Supplement

May 28, 2019
In Addition to Essential 9™, Sunshine Biopharma Launches 7 New Dietary Supplements Now Available on

May 16, 2019
Sunshine Biopharma Announces that Essential 9™ is Now Available in the United States on

March 12, 2019
Sunshine Biopharma Announces That ESSENTIAL 9™ Is Now Available On

February 4, 2019
Sunshine Biopharma Receives Notice Of Allowance For A New Patent Application Extending Protection Of Adva-27a Anticancer Drug Until 2033

December 17, 2018
Sunshine Biopharma Receives Health Canada Approval for Essential 9™, The Company's First Over The Counter Essential Micronutrient

December 12, 2018
Sunshine Biopharma Signs an Agreement With Crocus Laboratories for Manufacturing of Adva-27a Anticancer Drug

September 14, 2018
Sunshine Biopharma Announces $10 Million Equity Financing

August 16, 2018
Sunshine Biopharma Signs A Service Agreement With Utah Based Quintessential Biosciences Inc.

June 18, 2018
Sunshine Biopharma Launches Microbiology Testing Service

May 10, 2018
Sunshine Biopharma Annouces Extension Of The Term Of Its Brokered Up To $10 Million Private Placement Financing

January 4, 2018
Sunshine Biopharma Completes the Acquisition of Atlas Pharma